USANA Health Sciences sets Q2 2026 earnings release for August 4

0 min read     Updated on 15 Jul 2026, 03:51 AM
scanx
Reviewed by
Suketu GScanX News Team
AI Summary

USANA Health Sciences, Inc. announced the release of its second quarter 2026 financial results after the market close on August 4, 2026. A conference call is scheduled for August 5, 2026, at 11:00 a.m. Eastern Time to discuss the results with analysts and institutional investors.

powered bylight_fuzz_icon
45613294

*this image is generated using AI for illustrative purposes only.

USANA Health Sciences, Inc. will release its second quarter 2026 financial results after the market closes on Tuesday, August 4, 2026. The company will post its Management Commentary document on the Investor Relations website shortly following the earnings release. A conference call to discuss the results with analysts and institutional investors is scheduled for the following morning, Wednesday, August 5, 2026, at 11:00 a.m. Eastern Time.

The conference call will be broadcast live over the Internet and can be accessed through the company's Investor Relations website. USANA develops and manufactures nutritional supplements, functional foods, and personal care products sold directly to Brand Partners and Preferred Customers across 25 global markets.

Key Event Details

Event Date Time
Q2 2026 Earnings Release August 4, 2026 After market close
Conference Call August 5, 2026 11:00 a.m. ET

The company holds a 78.8% controlling ownership stake in Hiya Health Products, a children's health and wellness company, and a 100% interest in Rise Wellness. Hiya and Rise Wellness offer a variety of clean-label health products.

How will the performance of Hiya Health Products and Rise Wellness impact USANA's overall profitability in Q2 2026?

What strategies is USANA implementing to expand its market presence in the 25 global markets it operates in?

Will USANA provide any forward-looking guidance on revenue growth or earnings for the remainder of 2026 during the conference call?

like18
dislike
Must Read Next

Earnings

Corporate Actions

Stocks